These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8847906)

  • 1. HLA and Hodgkin's disease.
    Dorak MT; Mills KI; Poynton CH; Burnett AK
    Leukemia; 1996 Oct; 10(10):1671-2. PubMed ID: 8847906
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype associated: response to Dorak, Mills, Poynton and Burnett.
    Taylor GM; Gokhale DA
    Leukemia; 1996 Nov; 10(11):1850-1. PubMed ID: 8892697
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of the HLA-DP beta 1 locus by the polymerase chain reaction technique in patients with Hodgkin's disease.
    Pellegris G; Lombardo C; Cantoni A; Devizzi L; Balzarotti M
    Tumori; 1993 Apr; 79(2):133-6. PubMed ID: 8346566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DP based resistance to Hodgkin's disease.
    Bodmer JG; Tonks S; Oza AM; Lister TA; Bodmer WF
    Lancet; 1989 Jun; 1(8652):1455-6. PubMed ID: 2567468
    [No Abstract]   [Full Text] [Related]  

  • 5. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease.
    Oza AM; Tonks S; Lim J; Fleetwood MA; Lister TA; Bodmer JG
    Cancer Res; 1994 Oct; 54(19):5101-5. PubMed ID: 7923125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated.
    Taylor GM; Gokhale DA; Crowther D; Woll P; Harris M; Alexander F; Jarrett R; Cartwright RA
    Leukemia; 1996 May; 10(5):854-9. PubMed ID: 8656683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of HLA-DPB with Hodgkin's disease.
    Tonks S; Oza AM; Lister TA; Bodmer JG
    Lancet; 1992 Oct; 340(8825):968-9. PubMed ID: 1357360
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular genetic analysis of a family with a history of Hodgkin's disease and dyschondrosteosis.
    Gokhale DA; Evans DG; Crowther D; Woll P; Watson CJ; Dearden SP; Fergusson WD; Stevens RF; Taylor GM
    Leukemia; 1995 May; 9(5):826-33. PubMed ID: 7769845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DP class II antigens in transfusion-associated graft versus host disease.
    Nagumo F; Sano M; Tadano J; Katano M; Kubota E; Kikuchi M; Nose Y
    Lancet; 1993 Dec; 342(8884):1424. PubMed ID: 7901705
    [No Abstract]   [Full Text] [Related]  

  • 10. [HLA system antigens in Hodgkin's disease in children].
    Vuković I; Susaković N; Dujić A; Stojimirović E; Marković V
    Bilt Hematol Transfuz; 1977; 5(3-4):59-65. PubMed ID: 615611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of HLA antigens in patients with Hodgkin's disease.
    Prazák J; Hermanská Z
    Eur J Haematol; 1989 Jul; 43(1):50-3. PubMed ID: 2788584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation of HLA antigens to prognosis in Hodgkin's disease].
    Prazák J; Chytrý P; Hermanská Z
    Vnitr Lek; 1991; 37(9-10):781-8. PubMed ID: 1771812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).
    Alexander FE; Jarrett RF; Cartwright RA; Armstrong AA; Gokhale DA; Kane E; Gray D; Lawrence DJ; Taylor GM
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):705-9. PubMed ID: 11401923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etiological heterogeneity in Hodgkin's disease: HLA linked and unlinked determinants of susceptibility independent of histological concordance.
    Chakravarti A; Halloran SL; Bale SJ; Tucker MA
    Genet Epidemiol; 1986; 3(6):407-15. PubMed ID: 3803911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of a particular HLA-DP beta allele and an HLA-DQ heterodimer confers susceptibility to coeliac disease.
    Bugawan TL; Angelini G; Larrick J; Auricchio S; Ferrara GB; Erlich HA
    Nature; 1989 Jun; 339(6224):470-3. PubMed ID: 2498667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DPB1 associations differ between DRB1*03 positive anti-Jo-1 and anti-PM-Scl antibody positive idiopathic inflammatory myopathy.
    Chinoy H; Payne D; Poulton KV; Fertig N; Betteridge Z; Gunawardena H; Davidson JE; Oddis CV; McHugh NJ; Wedderburn LR; Ollier WE; Cooper RG;
    Rheumatology (Oxford); 2009 Oct; 48(10):1213-7. PubMed ID: 19690132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary evidence of an association between HLA-DPB1*0201 and childhood common acute lymphoblastic leukaemia supports an infectious aetiology.
    Taylor GM; Robinson MD; Binchy A; Birch JM; Stevens RF; Jones PM; Carr T; Dearden S; Gokhale DA
    Leukemia; 1995 Mar; 9(3):440-3. PubMed ID: 7885043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RFLP analysis with cDNA probes for DQ/DP region in HLA identical sibling marrow transplants: lack of correlation with GvHD.
    Gaozza E; Piccoli P; Ferrara GB; Bacigalupo A
    Haematologica; 1991; 76(1):8-13. PubMed ID: 1676012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
    Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.